KYMERA

Serial Number 90981116
Registration 7559572
700

Registration Progress

Application Filed
Nov 16, 2020
Under Examination
Oct 26, 2021
Approved for Publication
Aug 31, 2021
Published for Opposition
Aug 31, 2021
Registered
Nov 5, 2024

Trademark Image

KYMERA

Basic Information

Serial Number
90981116
Registration Number
7559572
Filing Date
November 16, 2020
Registration Date
November 5, 2024
Published for Opposition
August 31, 2021
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 5, 2024
Registration
Registered
Classes
042

Rights Holder

Kymera Therapeutics, Inc.

03
Address
500 North Beacon Street, 4th Floor
Watertown, MA 02472

Ownership History

Kymera Therapeutics, Inc.

Original Applicant
03
Watertown, MA

Kymera Therapeutics, Inc.

Owner at Publication
03
Watertown, MA

Kymera Therapeutics, Inc.

Original Registrant
03
Watertown, MA

Legal Representation

Attorney
Lisa M. Tittemore

USPTO Deadlines

Next Deadline
1827 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-05)
Due Date
November 05, 2030
Grace Period Ends
May 05, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Jun 6, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 6, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 6, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 5, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 5, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 12, 2024 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Sep 12, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 12, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 17, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Jul 17, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 10, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 10, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 26, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 26, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 26, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 26, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 26, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 26, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 26, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 12, 2024 INCD O ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST Loading...
May 24, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 26, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 26, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Apr 26, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 26, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Apr 26, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 26, 2024 IUAF S USE AMENDMENT FILED Loading...
Oct 19, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 17, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 17, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 17, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 18, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 18, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 21, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 19, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 19, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 19, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 27, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 25, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 25, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 26, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 31, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 31, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 11, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 27, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 2, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 2, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...

Detailed Classifications

Class 042
Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Research and development of pharmaceuticals, and research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Clinical studies; Preclinical and clinical development of therapeutic products
First Use Anywhere: Oct 31, 2017
First Use in Commerce: Oct 31, 2017

Additional Information

Design Mark
The mark consists of several geometric designs that form the basic elements of an animal face, with the wording "KYMERA" in capital stylized letters appearing to the right of the design and the "K" forming the base of the face.

Classification

International Classes
042